Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

SELL
$187.64 - $206.25 $9,757 - $10,725
-52 Reduced 0.48%
10,700 $2.06 Million
Q1 2023

Apr 20, 2023

BUY
$127.59 - $203.08 $36,618 - $58,283
287 Added 2.74%
10,752 $2.18 Million
Q4 2022

Jan 17, 2023

BUY
$117.37 - $139.17 $1.23 Million - $1.46 Million
10,465 New
10,465 $0
Q2 2022

Aug 01, 2022

BUY
$108.81 - $179.33 $38,953 - $64,200
358 Added 3.54%
10,465 $1.85 Million
Q2 2021

Jul 13, 2021

BUY
$135.08 - $161.1 $54,977 - $65,567
407 Added 4.2%
10,107 $1.54 Million
Q1 2021

May 10, 2021

BUY
$137.51 - $190.8 $1.05 Million - $1.46 Million
7,648 Added 372.71%
9,700 $1.35 Million
Q4 2020

Feb 04, 2021

BUY
$164.63 - $211.93 $337,820 - $434,880
2,052 New
2,052 $332,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.